Symptomtext
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 64 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Mar2021 (Lot number: EN6199) at the age of 63 years as dose 1, single for Covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: RASH (non-serious), PRURITUS (non-serious) all with onset 01Apr2021, outcome "not recovered" and all described as "About 3 weeks after first injection, developed itchy skin rash at inside left elbow (just below injection site).". The event "about 3 weeks after first injection, developed itchy skin rash at inside left elbow (just below injection site)", and "about 3 weeks after first injection, developed itchy skin rash at inside left elbow (just below injection site)". Was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rash, pruritus. Additional information: The patient receive no other vaccines within 4 weeks prior to the COVID vaccine. Patient received no other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The events cleared up after 3-4 weeks. No follow-up attempts are possible. No further information is expected.